One recent study has shown that YB-1 enforces lung cancer metastatic CSC-like properties in vitro and in vivo through transcriptional upregulation of NANOG, a marker of CSCs required for the invasion and sphere formation of ADC cells in vitro (Guo et al., 2017). Here, YBX1 is linked to lung carcinoma.